Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Dermatology · Folliculitis Decalvans

How Do Doctors Assess Folliculitis Decalvans Activity?

At a Glance

Doctors consider folliculitis decalvans active when new pus-filled bumps, redness, tenderness, or spreading hair loss appear. Smooth, stable bald scars usually reflect permanent past damage, so dermatologists monitor changes over time and may use close-up examination, photos, cultures, or biopsy.

Doctors determine whether Quinquaud folliculitis decalvans (FD) is active by looking for current signs of inflammation and checking if the hair loss is spreading [1][2]. Because FD is a scarring condition, it is common to worry that the disease is still active simply because you have smooth, hairless spots. However, hair loss is permanent where the follicles have been completely destroyed, meaning these hairless areas will remain even after the inflammation has stopped [3][4]. A quiet, stable scarred area without redness, pain, or new bumps suggests the condition may be inactive, but your dermatologist will monitor you over time to be sure [2][5].

Signs That Suggest Active Inflammation

FD is an inflammatory condition that damages hair follicles. While bacteria like Staphylococcus aureus are sometimes found in these areas, their presence does not definitively prove they are the sole cause of the disease [6]. When the disease is active, your doctor will look for:

  • Visible inflammation: New pus-filled bumps (pustules), crusts, sores, or discharge are classic signs of a flare [7][8].
  • Redness and scale: Even mild active FD can cause redness (erythema) and scaling (hyperkeratosis) around the hair follicles, without any pustules [7].
  • Symptoms: Worsening scalp pain, tenderness, burning, or itchiness can be clues that inflammation has returned [1][9]. However, some active disease can be subtle or asymptomatic.
  • Spreading hair loss: If the bald patches are demonstrably getting larger, the disease is likely still active [1][5].
  • New tufting: “Tufted hairs” (several hairs growing out of a single opening) are a characteristic consequence of scarring [10]. While tufts can remain as an old feature of scarring, newly appearing tufting at the edges of a patch can be a clue to ongoing damage [10].

Signs That Suggest the Disease Is Inactive (Remission)

Doctors generally consider FD to be in remission when there is a lack of inflammatory activity and the disease is stable [2][5]. This typically means:

  • No new pustules, crusts, or redness [2].
  • No significant pain, itching, or burning [5].
  • The size of the hairless patch is not changing over time [2].
  • Old scarring: The affected skin may look white, shiny, and completely smooth. Because the hair follicles have been destroyed, hair will not regrow here [3]. However, this lack of hair simply indicates prior damage, not necessarily current activity [2].

Remission is judged over time by your clinician, and it is important to remember that FD can relapse after a quiet period.

How Doctors Evaluate Your Scalp

To tell the difference between old scars and active disease, dermatologists use several complementary tools:

  • Trichoscopy: Doctors use a handheld magnifying device to look closely at your scalp. Trichoscopy can reveal hidden redness, tiny pustules, and abnormal blood vessels if the disease is active [10][11]. It can also document scarring by showing a lack of follicular openings (pores) [4]. However, no single trichoscopic sign independently proves activity or remission.
  • Serial Photographs: Taking standardized photos of your scalp helps objectively measure whether the hairless patches are expanding [11]. You can also track this at home by taking photos of the same areas with consistent lighting, parting, and camera distance to share with your doctor.
  • Bacterial Culture: If you have persistent, recurrent, or unusually purulent lesions, your doctor may swab them [6]. While this identifies bacteria, a positive result must be interpreted alongside your symptoms to help guide your treatment plan [12].
  • Scalp Biopsy: If it is difficult to tell if inflammation is still happening, a small skin sample can be examined under a microscope [13]. Because a biopsy only samples a small area, your dermatologist will carefully choose the site and interpret the results alongside your clinical picture [14].

When to Contact Your Doctor Early

Do not wait for your next scheduled appointment if you notice signs that the disease is waking up. Contact your doctor earlier if you develop new painful bumps, spreading redness, increased tenderness, or if you feel your hairless patch is actively getting larger. Catching a flare-up early may reduce the risk of further permanent hair loss [3].

Seek urgent medical care if you experience rapidly spreading warmth and redness, severe pain, fever, facial swelling, or significant drainage, as these could indicate a more serious secondary skin infection rather than routine FD activity.

Common questions in this guide

What signs suggest that folliculitis decalvans is active?
Active folliculitis decalvans may cause new pus-filled bumps, crusts, sores, discharge, redness, scaling, pain, tenderness, burning, or itching. Hair loss that is spreading or new clusters of hairs growing from one opening at the edge of a scarred area can also suggest ongoing inflammation, although active disease can sometimes be subtle.
Does a smooth bald patch mean my folliculitis decalvans is still active?
Not necessarily. A smooth, white or shiny, stable hairless patch often represents old scarring after the follicles have been destroyed, so hair may not regrow there. Doctors look for new inflammation or changes over time rather than judging activity from hairlessness alone.
How do dermatologists check whether folliculitis decalvans is in remission?
Dermatologists examine the scalp for inflammation, use a close-up magnifying examination, compare standardized photographs over time, and assess whether symptoms or the patch size have changed. If activity remains uncertain, they may culture persistent pus-filled lesions or perform a scalp biopsy.
Can folliculitis decalvans become active again after remission?
Yes. Folliculitis decalvans can relapse after a quiet period, so remission means the disease is currently stable rather than permanently cured. New pustules, redness, tenderness, burning, or spreading hair loss should be reported to your dermatologist.
When should I contact my doctor about a possible folliculitis decalvans flare?
Contact your doctor early if you develop new painful bumps, spreading redness, increased tenderness, or a hairless patch that seems to be enlarging. Seek urgent medical care for rapidly spreading warmth and redness, severe pain, fever, facial swelling, or significant drainage.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Folliculitis decalvans: a multicentre review of 82 patients.

    Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.

    PMID: 25682915
  2. 2

    Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.

    Al-Naesan I, Trafoier T, Krepper D, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.

    PMID: 42750403
  3. 3

    Hair and Nail Conditions: Alopecia Evaluation.

    Wu S

    FP essentials 2022; (517()):11-16.

    PMID: 35679467
  4. 4

    Validity of trichoscopy in the diagnosis of primary cicatricial alopecias.

    Abedini R, Kamyab Hesari K, Daneshpazhooh M, et al.

    International journal of dermatology 2016; (55(10)):1106-14 doi:10.1111/ijd.13304.

    PMID: 27061072
  5. 5

    Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.

    Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.

    Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.

    PMID: 29864465
  6. 6

    Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.

    Lyakhovitsky A, Segal O, Galili E, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.

    PMID: 37875786
  7. 7

    Management of folliculitis decalvans: The EADV task force on hair diseases position statement.

    Waśkiel-Burnat A, Starace M, Iorizzo M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.

    PMID: 40230058
  8. 8

    Successful Management of Folliculitis Decalvans.

    Kashikar Y, Saoji V, Madke B, et al.

    Cureus 2024; (16(1)):e52881 doi:10.7759/cureus.52881.

    PMID: 38406166
  9. 9

    Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.

    Pimenta R, Borges-Costa J

    Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.

    PMID: 31032795
  10. 10

    Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series.

    Uchiyama M, Harada K, Tobita R, et al.

    Journal of the American Academy of Dermatology 2021; (85(5)):1185-1193 doi:10.1016/j.jaad.2020.03.092.

    PMID: 32272176
  11. 11

    Epidemiological, Clinical, and Therapeutic Insights into Folliculitis Decalvans in Skin of Color: A Retrospective Descriptive Study of 17 Cases.

    Loubaris Z, Taib HE, Benzekri L, Meziane M

    Skin appendage disorders 2025; (11(6)):482-487 doi:10.1159/000546565.

    PMID: 40584732
  12. 12

    Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.

    Samrao A, Mirmirani P

    Dermatology online journal 2020; (26(2)).

    PMID: 32239885
  13. 13

    Scalp Biopsies for Alopecia.

    Brunetti T, Misciali C, Rapparini L, et al.

    Dermatopathology (Basel, Switzerland) 2026; (13(3)) doi:10.3390/dermatopathology13030044.

    PMID: 42782841
  14. 14

    Line Field Confocal Optical Coherence Tomography (LC-OCT) Features of Primary Cicatricial Alopecias.

    Traini DO, Palmisano G, Ciobotariu I, et al.

    International journal of dermatology 2026; (65(8)):1641-1646 doi:10.1111/ijd.70266.

    PMID: 41532173

This page is for informational purposes only and does not constitute medical advice. It explains general ways dermatologists assess folliculitis decalvans; consult your dermatologist for symptoms, diagnosis, or treatment decisions.